Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Army
Federal Trade Commission
Cipla
Covington
QuintilesIMS
Medtronic
Farmers Insurance
Citi

Generated: June 19, 2018

DrugPatentWatch Database Preview

CISPLATIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cisplatin, and what generic alternatives are available?

Cisplatin is a drug marketed by Accord Hlthcare, Bedford, Fresenius Kabi Usa, Gland Pharma Ltd, Hq Spclt Pharma, Mylan Labs Ltd, Pharmachemie Bv, Teva Pharms Usa, and West-ward Pharms Int. and is included in nine NDAs.

The generic ingredient in CISPLATIN is cisplatin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cisplatin profile page.

US Patents and Regulatory Information for CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare CISPLATIN cisplatin INJECTABLE;INJECTION 206774-001 Aug 18, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd CISPLATIN cisplatin INJECTABLE;INJECTION 091062-001 Apr 18, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa CISPLATIN cisplatin INJECTABLE;INJECTION 074735-001 Jul 16, 1999 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmachemie Bv CISPLATIN cisplatin INJECTABLE;INJECTION 074656-001 May 16, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CISPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 ➤ Sign Up ➤ Sign Up
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 ➤ Sign Up ➤ Sign Up
Hq Spclt Pharma CISPLATIN cisplatin INJECTABLE;INJECTION 018057-004 Nov 8, 1988 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Deloitte
Mallinckrodt
AstraZeneca
QuintilesIMS
Daiichi Sankyo
Johnson and Johnson
Baxter
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.